Zhang P, Lavoie PM, Lacaze-Masmonteil T, Rhainds M, Marc I. (2014) Pediatrics. peds.2014-0459. [Epub ahead of print]
BACKGROUND AND OBJECTIVE:
Omega-3 long chain polyunsaturated fatty acid (LCPUFA) exposure can be associated with reduced neonatal morbidities. We systematically review the evidence for the benefits of omega-3 LCPUFAs for reducing neonatal morbidities in extremely preterm infants.
Data sources were PubMed, Embase, Center for Reviews and Dissemination, and the Cochrane Register of Controlled Trials. Original studies were selected that included infants born at
Large-scale interventional studies are required to determine the clinical benefits of omega-3 LCPUFA, specifically in extremely preterm infants, during the neonatal period.
Copyright © 2014 by the American Academy of Pediatrics.